CPHI vs MAS · rev $4.1M vs P/E 18, rev $7.83B
China Pharma Holdings Inc (CPHI) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
CPHI currently screens at market cap $29.0M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the CPHI and MAS stock pages for the full models.
Not investment advice.